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A.S.P.E.N. Ethics Position Paper    
 
A.S.P.E.N. Ethics Position Paper Task Force: Albert Barrocas MD FACS  Chair; Cynthia 
Geppert, MD, PhD, MPH, FAPM, DAAPM; Sharon M. Durfee, RPh, BCNSP; Julie O'Sullivan 
Maillet RD, PhD; Cheryl Monturo , PhD, APRN; Charles Mueller, PhD, RD, CNSD; Kathleen 
Stratton, JD, RD, LDN; Christina Valentine, MD, RD and the A.S.P.E.N. Board of Directors  
 
Introduction 
 
Purpose  
 Position papers provide the opinions, guidance and recommendations of a group or 
organization based on a consensus of evidence-based medicine (EBM), expert opinion, best 
practices, and clinical experience current at the time of development. This position paper’s 
purpose is to provide a critical summary of the major ethical and legal issues related to the 
provision of artificial nutrition and hydration (ANH), to provide guidance for practitioners 
confronted with these dilemmas, and to direct readers to additional references for further 
study.  
The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) is an 
organization comprised of healthcare professionals representing the disciplines of medicine, 
nursing, pharmacy, dietetics, and nutrition science. The mission of A.S.P.E.N. is to improve 
patient care by advancing the science and practice of nutrition support therapy. A.S.P.E.N. 
vigorously works to support quality patient care, education, and research in the fields of 
nutrition and metabolic support in all healthcare settings. Under the guidance of the A.S.P.E.N. 
Board of Directors, the Ethics Position Paper Task Force developed recommendations based 
upon general conclusions of experienced healthcare professionals and ethicists working in the 
field of nutrition support, and as an extension of previously published guidelines. The Task 
Force, in developing such a position, has balanced potential benefits to be derived from a 
particular mode of nutrition support therapy against inherent risks associated with such therapy 
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within an overall framework of ethical principles and values. The professional judgment of the 
attending health professional, however, is the primary component of quality health care. 
Because these recommendations cannot account for every variation in circumstances, the 
practitioners must always exercise professional judgment in their application. This position 
paper is intended to supplement, but not replace, professional training and judgment. 
Intended Audience and How to Use this Document 
 While useful to a heterogeneous group of individuals, the intended users of this position 
paper are clinicians caring for patients and families faced with ethical and legal concerns 
involving ANH. The paper is not intended to be a full review of the clinical or even ethical and 
legal aspects of ANH or the medical disorders for which it is commonly utilized. This paper 
outlines the major ethical positions of A.S.P.E.N. regarding a variety of clinical situations 
concerning ANH. Extended discussions of particular areas and additional reference material 
are available on the A.S.P.E.N. website at www.nutritioncare.org/ethics. 
 
A.S.P.E.N. Ethics Position Paper Summary   
 
It is the position of A.S.P.E.N. that:  
1. To the extent possible, decisions regarding ANH should be based on EBM, best practices, 
and clinical experience and judgment in discussion with the patient, family, or significant 
others. Page 5 
2. From a scientific, ethical, and legal perspective there should be no differentiation between 
withholding and withdrawing of ANH, thus this paper employs the term “forgoing” for both, 
recognizing that withdrawing is more emotionally laden than withholding, especially within 
specific cultures. Page 5 
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3. Decisions regarding forgoing ANH should incorporate a benefit-risk-burden analysis based 
on EBM and best practices in discussion with the patient, family, or significant others. Page 6 
4. Limited time trials are an acceptable alternative when the benefits of ANH are questionable 
and the trial nature of ANH is communicated and consented to by the patient and family prior 
to its initiation. Page 6 
5. Scientific evidence on the physiology of patients with brain death, in a coma, or in a 
persistent vegetative state (PVS), indicates these patients do not experience thirst or 
hunger, and therefore are not likely to suffer. Page 6 
6. ANH may not provide any benefit and may have associated risks in patients with severe 
dementia or in a PVS. Page 6-7 
7. Artificial hydration of terminally ill patients can lead to discomfort due to fluid overload, 
pulmonary and generalized edema, shortness of breath, etc. and may be discontinued on 
clinical and ethical grounds provided such discontinuation is not in conflict with existing 
laws, institutional policies and consent/consensus of decision makers. Page 8-9 
8. Forgoing ANH in infants and children at the end of life may be ethically acceptable when 
competent parents and the medical team concur that the intervention no longer confers a 
benefit to the child or creates a burden that cannot be justified. Page 9-11 
9. The religious, cultural and ethnic background of patients and families need to be respected 
to the extent it is consistent with other ethical principles and duties. Page 8 
10. Consent, respect, and preservation of dignity should be paramount during ethical and legal 
deliberations regarding ANH. Page 14 
11. Many states in the U.S. require “clear and convincing evidence” to forgo ANH in 
decisionally incapacitated patients without documented ANH preferences. Page 16 
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12. Patients with decision-making capacity and authority should be the appropriate moral 
agents to make choices regarding ANH based on evidence-based information qualified 
practitioners present to them. Page 16 
13. For patients lacking decision-making capacity, the health care professional has an ethical 
and legal obligation to reference an advance directive or discussion with the authorized 
surrogate decision maker, whether appointed through mechanisms of a durable power of 
attorney for health care directive, court or statutory processes. Page 16-17 
14. Surrogate decision makers (including but not limited to family members and/or significant 
others) should be given the same considerations as individual patients with decision-
making capacity. Page 16 
15. Health care professionals should not be ethically obligated to offer ANH if in their clinical 
judgment there is not adequate evidence for the therapy, or the burden or risk of the 
intervention far outweighs its benefit. Page 12 
16. The establishment of interdisciplinary teams and conferences with the patient and family is 
highly encouraged. Interdisciplinary ethics committees or panels should be consulted when 
the involved parties cannot resolve the ethical dilemma. Page 13 
17. Care should continue until the conflict regarding ANH is resolved.  If unable to resolve 
conflicts, even with an ethics consultation, orderly transfer of care assuring continuity of 
care is recommended to an equally qualified and willing practitioner and/or institution.  At 
no time should patients or families feel abandoned. Page 13 
Definitions  
 
 Definitions of ethical terms can be found in a glossary on the ethics position portion of 
our website (www.nutritioncare.org) and should be used in conjunction with the A.S.P.E.N. 
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Definition of Terms, Style, and Conventions Used in A.S.P.E.N. Board of Directors-Approved 
Documents which can also be found on the website (www.nutritioncare.org). 
The Ethics of ANH in Specific Patient Conditions 
 There are many clinical conditions for which various types of ANH are utilized. While 
ethical issues can arise in the management of any of these disorders, they are most commonly 
encountered in the management of dementia, persistent/permanent vegetative states, and 
terminal illness. Shared decision-making about the use of ANH in these clinical situations 
should take into consideration ethical, legal, religious and cultural aspects discussed later in 
this paper. From a scientific, ethical, and legal perspective there should be no differentiation 
between withholding and withdrawing of ANH. Thus this paper employs the term “forgoing” for 
both, recognizing that withdrawing is more emotionally laden than withholding, especially 
within specific cultures. The decision to forgo ANH should be based on EBM, illness trajectory, 
the expected impact of the intervention on the disease/condition, expected clinical outcomes 
and the preferences and values of the patient or authorized surrogated decision-maker. 
ANH is a viable and highly effective therapy to ameliorate the effects of temporary or 
chronic conditions for those unable to ingest food and fluids.1 An ethical dilemma can be  
created when ANH treatment is not clinically indicated, ineffective or  potentially harmful such 
as the risk of aspiration pneumonia with enteral nutrition for advanced dementia. Despite the 
clinical evidence, some patients and families believe that the forgoing of artificial nutrition is 
cruel, inhumane, or equivalent to starvation.2 The basis for an ethically sound decision to forgo 
ANH should be based on the risk-benefit-burden analysis of ANH as well as the wishes of the 
patient and/or surrogate. In each of these conditions, limited time trials may be an acceptable 
alternative when the risk/burden-benefit ratio of ANH is uncertain or there is not consensus 
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among the involved practitioners. However, the trial nature of the intervention and the criteria 
and timeframe for reevaluation of the intervention should be clearly communicated to the 
patient and family prior to initiation of the trial. 
Persistent vegetative state (PVS) is a state of prolonged unresponsiveness without 
awareness due to overwhelming dysfunction of cerebral hemispheres with preservation of 
brainstem function as evidenced by autonomic and motor reflexes- eye movements, yawning, 
involuntary movement to noxious stimulus and sleep/wake cycles.3   PVS is characterized by 
wakefulness without awareness.  It has a poor prognosis for recovery of awareness when 
present for more than a year in trauma patients and more than 3-months in all non trauma 
patients at which time it has a high probability of becoming a permanent vegetative state.4  
 Neuroscientific evidence suggests that patients who are comatose, or in a truly 
persistent vegetative state, do not experience suffering from thirst or hunger while patients in 
minimally responsive states or where some degree of consciousness is preserved do suffer. 
These distinctions have clinical ethics implications for risk-benefit-burden analysis. For 
instance, when the prognosis or cognitive state is uncertain such as early in the course of brain 
injury then a time-limited trial of ANH may be both clinically and ethically warranted provided 
the goals of such a trial are clearly understood and accepted by all parties involved. However, 
when the diagnosis has been determined with reasonable scientific certitude and the result of 
prior patient preferences or a process of shared decision making with family and/or the 
surrogate finds ANH to be excessively burdensome for that individual, then it can be forgone.5   
 Advanced dementia is a state of chronic, global, usually irreversible deterioration of 
cognition affecting primarily the elderly, although it can happen at an earlier age.  Dementias 
may be primary neurodegenerative disorders, e.g. Alzheimer’s disease, Parkinson’s disease, 
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chronic alcohol abuse, infectious causes; or due to another condition such as vascular 
disease.3    In advanced dementia, patients cannot feed, walk, or perform activities of daily 
living.  They eventually become mute and often have dysphagia  and cognitive deficits that  
impede normal intake making these patients candidates for nutrition support, specifically 
enteral (tube) nutrition since gastrointestinal function is not otherwise compromised.  A survey 
of nursing home residents in the United States with advanced dementia found that 34% of 
186,835 were tube fed.6  In 1999 Finucane and colleagues noted in a review of the literature 
that enteral nutrition did not improve clinical outcome in advanced dementia.7 In 2008 a 
Cochrane database and literature review concluded that there was insufficient evidence to 
suggest that enteral nutrition benefits patients with advanced dementia and that data on 
adverse events associated with enteral nutrition are lacking.6 Both of these studies concluded 
that there is little efficacy for enteral nutrition in this population. 
The American Dietetic Association recommends that the use of enteral nutrition in severe 
dementia may be justified by specific and limited goals. As the Association’s position states, 
however, tube feeding can be ethically rejected when all involved understand the realistic 
outcomes of enteral nutrition.8 Many patients, families and non-specialist clinicians 
misunderstand or overestimate the benefits of ANH in advanced dementia which can lead to 
ethical dilemmas that evidence based education and counseling may constructively address.  
In patients with advanced dementia, ANH has not been shown to promote the healing of 
pressure ulcers, reduce the risk of aspiration pneumonia, increase patient comfort, functional 
status or prolong survival when compared to hand-feeding. A review of 5266 nursing home 
residents with dysphagia failed to show benefit from placement of a feeding tube and found a 
higher 1-year mortality rate.7  
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Finally, it is important to note that some patients with advance dementia and the ability to 
consume food orally may receive ANH in lieu of hand feeding. This may be due to institutional 
culture9, reimbursement and regulatory considerations, or a lack of adequate staff10, or a 
neglect for the inherent meaning of food and the societal nature of mealtime, all of which have 
ethical implications.   
End stage disease/terminal illness  
ANH is often initiated during the treatment phase of care and may be especially useful 
in patients with GI obstruction. When terminally ill patients progress to hospice care, the role of 
ANH, as with all interventions, needs to be re-evaluated in terms of the goals of comfort, relief 
of symptoms, and quality rather than quantity of life.11 The majority of terminally ill patients will 
reach a point in their illness where they either refuse food or are unable to take nutrition orally. 
Families may feel a moral duty and emotional need to provide food and water to their dying 
loved ones. It is thus important to discuss with patients and families that loss of the desire to 
eat and drink is a natural part of the dying process. The risks, benefits, and burdens of ANH at 
the end-of-life along with relevant cultural and religious values and patient and family 
preferences and values must be weighed in each individual case.12 
 ANH in dying patients has been associated with increased nausea, vomiting, and 
diarrhea and repeated aspiration pneumonia,13 while fluids may cause or exacerbate dyspnea, 
bronchial secretions, urinary frequency, bladder distention, pulmonary edema and effusions 
and ascites.14 The administration of ANH often requires the need for additional interventions 
such as catheters, blood draws, restraints and medications to manage complications of 
nutrition and hydration, which may cause discomfort. Ironically ANH can prevent the ketosis 
and dehydration that are a protective mechanism against potentially painful symptoms of 
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dying. A study with terminally ill patients found that most did not experience hunger or  that 
hunger  was satisfied with small amounts of food. Feelings of thirst were relieved with sips of 
liquid and mouth care.15 Hospice nurses working with dying patients reported that those who 
voluntarily refused both food and fluids experienced a good death within 2 weeks.16 In a study 
in cancer patients undergoing hematopoietic stem cell transplantation, it was reported that 
patients receiving parenteral nutrition had lower oral intake and higher fevers and infections as 
compared to patients not receiving parenteral nutrition.17  Research has not shown that ANH 
prolongs life in patients with certain specific serious and terminal conditions.18,19 
Special Considerations for Infants and Children 
Legal authority to make life and death decisions for children generally20  and for 
neonates specifically has historically been left to parents.21 While there is specific federal 
legislation that applies in the case of infants, decisions for children are generally guided by the 
common law and statutes that will vary from state to state.20 A clear understanding of clinical 
circumstances is vital to anticipate care for families.22 Artificial support is a common practice as 
care decisions are being made in a terminally ill newborn. Each different clinical scenario 
requires a practitioner to evaluate the potential outcome in regard to the  futility or realistic 
chance of improvement.23,24 ANH is integral for the care of a newborn and difficult to forgo.25 
The forgoing of fluids and nutrition to a neonate can evoke strong emotional reactions since 
feeding is fundamental to infants, who possess no autonomy in the decision.26 
The 1983 much publicized “Baby Doe” case involved an infant with Down’s syndrome 
and esophageal atresia in which the parents and physicians chose to defer surgery and 
nutrition support, with the infant subsequently dying 6 days afterward. This case prompted the 
Department of Health and Human Services to issue a federal ruling entitling anyone to report a 
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case whereupon “medical treatment or food was withheld from defective infants”. 27 Thereafter, 
in 1984, Congress amended the Child Abuse Prevention and Treatment Act (CAPTA) to 
include language intended to protect disabled infants from medical neglect. 28 The law defines 
medical neglect to include “the withholding of medically indicated treatment.” 29 Current federal 
regulations promulgated under the authority of CAPTA include nutrition and hydration within 
the definition of “medically indicated treatment” for disabled infants.30  While CAPTA and the 
regulations do create an exception for when in a physician’s reasonable judgment an infant is 
“chronically and irreversibly comatose,” when treatment would “merely prolong dying,” or be 
“futile” or “inhumane,” it also excludes nutrition and hydration from this exception. 
In a 2009 clinical report, the American Academy of Pediatrics (AAP) offered general 
principles designed to help practitioners decide when it is ethically permissible to forgo 
medically provided fluids and nutrition from infants, children, and adolescents.31 The AAP 
report also addresses  CAPTA, as it applies in the case of infants only.28,30 In this report, the 
AAP also takes the position that although the language of CAPTA and the regulations “seem to 
advocate for the provision of appropriate fluids and nutrition in most cases,” forgoing ANH is 
ethically acceptable with competent parents when the intervention no longer confers a benefit 
to the child or creates a burden that cannot be justified. 31 The AAP also points out that while 
CAPTA makes states’ receipt of federal child abuse prevention program funding contingent 
upon having appropriate reporting mechanisms in place, there is no direct enforcement 
mechanism to the law. They therefore argue that CAPTA and the supporting regulations “were 
not intended as standards of physician or institutional liability.” 31  In an earlier report from1994, 
the AAP Committee on Bioethics provided a framework for documentation of medical futility, 
discussions with parents of treatment options, corroborating statements from other physicians, 
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and the process of a bioethics committee review to help protect the infant but also to provide 
the most humane treatment. 32 Open communication with parents and realistic prognostic 
outlooks for their infant from the beginning is crucial to help avoid conflicts in providing or 
withdrawing care. 33. 
Ethical Decision Making Background  
 
Bioethical theory 
 
Bioethics is a form of normative ethics: the branch of philosophical ethics concerned 
with formulating general standards or norms of ethical behavior and moral judgment. Ethical 
dilemmas are situations in which an individual is faced with two ethically acceptable courses of 
actions or decisions but it is not possible to fufill both moral requirements. For example, a 
clinician may wish to respect a family’s wishes that a dying patient receive ANH but also to 
honor his duty to avoid harming the patient through a burdensome treatment with 
complications. Ethical theories propose a set of coherent principles, obligations or virtues that 
can serve as the basis for evaluation of actions, decision-making and ethical reasoning. When 
these theories are used to analyze specific issues, such as forgoing of ANH in persons with 
advanced dementia, this is an example of applied ethics.34 The three main groups of theories 
which are most relevant to the nutrition support clinician are: deontological, consequentialist 
theories, of which the most well known is utilitarianism, and principlism. Deontology derived 
from the philosopher Immanuel Kant, posits near absolute duties such as respect for the innate 
dignity of human beings.  An action or decision is right when it fulfills and wrong when it 
abrogates these universal obligations.  Consequentialism originating in the thought of John 
Stuart Mill is widely used in public health and health policy with the goal of obtaining the 
greatest good or happiness for the most people. Utilitarian theory would weigh the risks, 
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benefits, and burdens or calculate a cost/benefit analysis of a proposed nutrition support 
intervention for a particular patient and a population as a whole.  Principlism grounds ethical 
decisions and formulates arguments through the specification and balancing of a set of core 
ethical principles: autonomy, beneficence, nonmaleficence, and justice.35 These principles 
are further elaborated upon at www.nutritioncare.org/ethics. 
 Considerations and Models for Resolving Ethical Dilemmas   
 
Ethical dilemmas are situations in which nutrition support clinicians are commonly 
confronted with conflicts between clinical, legal and ethical obligations. Health care 
professionals should not be ethically obligated to offer ANH if in their clinical judgment there is 
not adequate evidence for the therapy, or the burden or risk of the intervention far outweighs 
its benefit.  This recommendation should be considered even if families or patients request 
ANH be initiated or continued. The practitioner does have an ethical obligation to try and 
resolve the conflict. 
 The use of interdisciplinary teams and conferences with the family and patient can 
often resolve the conflicts through informal mechanisms. In addition several formal approaches 
to resolving ethical dilemmas are available to assist the practitioner in identifying, analyzing 
and resolving these dilemmas. The four-box method of Jonsen, Winslade and Siegler 36 
analyzes clinical indications, patient preferences, quality of life and contextual features of each 
case to facilitate thought about difficult ethical issues. Barrocas has constructed conceptual 
templates entitled the “12Cs” of considerations important to nutrition support decisions.37  
When ethical conflicts cannot be resolved through these approaches, then practitioners 
should consider consulting the facility ethics committee or ethics consultation service for 
assistance. The responsible practitioners should continue to provide care for the patient until 
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the conflict regarding ANH is resolved and at no time should the patient be abandoned. If even 
ethics consultation cannot develop a consensus among all parties, and a clinician feels that he 
cannot in conscience remain involved in the patient’s care, then orderly transfer to an equally 
competent and willing practitioner or institution is ethically appropriate.  
Cultural and Religious Considerations 
 
          Cultural values and religious beliefs are far more powerful and pervasive factors in 
decisions regarding ANH than in those involving almost any other modern medical 
intervention. The associations of food/ feeding and fluids/drinking with care-giving, sustenance 
and survival carry an emotional valence for patients and families deserving practitioners’ 
understanding and empathy.38 Clinician’s failure to identify and be responsive to these 
humanistic concerns can precipitate ethical conflicts.  Recognizing that it is impossible to 
develop expertise regarding the beliefs and practices of the diverse faith and ethnic groups in 
our multicultural society, practitioners should endeavor to learn about the relevant religious 
positions and cultural attitudes comprising their patient population, learn the questions to ask 
and listen to the patients.39 Clinicians should also be aware that the inherent culture of an 
institution, such as a nursing home, may also influence the decision to use ANH.9  
Clinicians should show sensitivity and respect for the individual faith commitments and 
cultural preferences of patients regarding ANH even when they do not agree with them from a 
medical perspective. In some situations in which religious or culturally based treatment 
preferences for the continuation of ANH conflict with medical recommendations, respect for 
patient self-determination and dignity may outweigh clinical determinations recognizing that 
many aspects of risk-benefit-burden assessments are also value judgments.  Practitioners 
confronted with these common and challenging dilemmas may want to work with the  patient 
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and/or surrogate in consulting with faith leaders and the ethnic community to which the patient 
belongs as well as the institutional ethics committee. It is important to note that if these efforts 
do not resolve the issue, orderly transfer of care should be initiated so that the patient not be 
abandoned. 
 Catholic and Judaic viewpoints on ethical issues related to ANH have received 
considerable organizational and scholarly attention; however most other religious and cultural 
views are minimally represented in the U.S. medical literature. This discussion, therefore, is 
not intended to be comprehensive. There are three main issues that practitioners may 
encounter in clinical practice. First, while individual autonomy is the predominant force in 
Anglo-American decision-making, some members of Native American, Asian and Hispanic 
groups may exercise autonomy communally or through the family.40-42  
 Second, religious beliefs played a role in the Schiavo feeding tube controversy where a 
surrogate’s request for tube removal was repeatedly challenged in court despite an established 
legal and ethical consensus supporting the decision. While this consensus was ultimately 
upheld, the media coverage and politicization of this case left many Roman Catholic patients 
and providers confused whether ANH can be withheld or withdrawn in a variety of conditions.43 
Similarly, the 2004 papal allocution suggesting an obligation to utilize ANH in persistent 
vegetative states44 and the 2009 United States Conference of Catholic Bishops decision to 
revise the Ethical Directive on Nutrition and Hydration to contain a similar duty45 illustrate the 
contemporary power of religious values to influence ANH decision making and the need for 
expert consultation. 
 Third, it is not only patients but also health care professionals whose religious beliefs 
and cultural values may conflict with clinically grounded recommendations to forgo ANH in 
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advanced dementia, PVS or at the end of life. State laws, professional codes of ethics, facility 
bylaws and institutional policies often contain conscience clauses that enable health care 
practitioners to be recused from the clinical treatment of a patient on moral or religious grounds 
if an equally qualified practitioner is available and willing to assume care of the patient. 46  
Legal Summary  
The law concerning ANH at the end of life is subject to the actions of state legislatures 
and courts and evolves over time as the public and legislators contemplate contested cases. 
Basic legal principles that courts rely on include the common law doctrine of informed consent, 
which is firmly entrenched in the law and includes the right of a competent person to refuse 
medical treatment. 47 Courts will also look to state statutes and constitutional authority for 
guidance. In the 1976 Quinlan case, the New Jersey Supreme Court relied on the 
constitutional right to privacy to allow cessation of medical treatment, in that case artificial 
ventilation.48 Later, in the 1990 Cruzan case, the United States Supreme Court dealt directly 
with a case in which a guardian sought to stop ANH in a patient determined to be in a PVS.47 
Referring to the 14th Amendment Due Process clause, the Court stated that while a competent 
person has “a constitutionally protected right to refuse lifesaving hydration and nutrition,” the 
individual’s liberty interest must be balanced against relevant state interests, such as the 
preservation of life. The Court then held that a state (Missouri) could apply a “clear and 
convincing evidence standard” (a high legal standard) in looking for proof of the patient’s 
wishes concerning ANH in the end of life. A majority of state courts will apply the “clear and 
convincing” evidence standard but what type of evidence satisfies that standard can vary from 
state to state.49  
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Taking these basic principles into consideration, if a competent person is presented with 
a recommendation that ANH be initiated, care providers should educate that patient about the 
risks, benefits, and burdens of ANH so that the patient can make an informed decision about 
whether ANH is warranted. When a previously competent person, through accident or illness, 
suddenly becomes incapacitated and is unable to make health care decisions, health care 
providers must look to advance directives for previously expressed communication as to what 
type of life-sustaining treatment the patient desires, if at all. Surrogate decision makers 
(including but not limited to family members and/or significant others) should be given the 
same considerations as individual patients with decision-making capacity Advance directives 
take different forms depending on the laws of the jurisdiction involved and the patient’s wishes. 
These may include living wills (instructions for care) and/or a health care proxy (designates a 
person to carry out instructions), such as a durable power of attorney for health care, among 
other forms.50 Some patients will have advanced directives prepared by attorneys as part of 
their end of life planning. Others might have prepared a living will by utilizing the help of their 
physician or an organization’s website. Examples of websites that provide end of life planning 
guidance include Caring Connections, a program of the National Hospice and Palliative Care 
Organization (NHPCO)51 and Aging with Dignity, a national non-profit organization.52 
 However, a patient who is being considered for ANH may not have prepared an 
advance directive. A recently published study showed between 2000 and 2006, many elderly 
Americans needed decision making near the end of life at a time when most lacked the 
capacity to make decisions. Patients who had prepared advance directives (67.5% of this 
group) received care that was strongly associated with their preferences. These findings 
support the continued use of advance directives.53 Legal conflicts may arise when a patient 
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who has not provided the health care team with an advance directive addressing ANH loses 
the capacity to speak for him or herself and conflicts between family members or caregivers 
arise. The 2005 Terry Schiavo case in Florida is one such example.54 The same dilemma may 
arise if a patient is incompetent from the outset and there is no legal guardian or agent who 
has the legally appointed right/duty to make decisions on behalf of the patient. While 
established legal precedent guides the courts, each case has unique facts and state laws vary 
in how they protect patients’ rights. While one state may allow oral substituted judgment of a 
patient’s desires, another may require written evidence.50 A practitioner must therefore be 
aware of the most current version of the laws at work protecting patients’ rights in the particular 
state in which one practices. This includes state statutes, constitutions, and the legal 
precedent as set forth in the state’s appellate court decisions. 
Conclusion 
 
The purpose of this A.S.P.E.N. position paper is to provide a critical summary of the 
major ethical and legal issues related to the provision of artificial nutrition and hydration (ANH), 
to provide guidance for practitioners, patients, and families confronted with these dilemmas, 
and to direct readers to additional references for further study. This paper also outlines the 
major ethical position of A.S.P.E.N. regarding the use of ANH in three of the most commonly 
encountered and controversial clinical conditions: persistent vegetative states, advanced 
dementia, and terminal illness. The position paper also underscores the importance of religious 
beliefs and cultural values the decisions of patients and families regarding the provision of 
ANH. Finally, the position paper presents a summary of key legal cases and rulings, and  
outlines major ethical principles and theories, which provide the framework within 
contemporary clinical decisions about ANH are made. Effective communication amongst all 
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involved parties is of paramount importance in dealing with ethical and legal issues concerning 
ANH.   It is hoped that the health care provider will be successful in achieving this goal with the 
aid of this position paper and the supporting documentation on the ASPEN Ethics website. 
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